Stratos Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.3M Buy
16,610
+2,676
+19% +$2.71M 0.61% 42
2025
Q4
$15M Buy
13,934
+321
+2% +$307K 0.6% 41
2025
Q3
$10.4M Buy
13,613
+246
+2% +$183K 0.43% 58
2025
Q2
$10.4M Buy
13,367
+5,083
+61% +$3.95M 0.48% 52
2025
Q1
$6.84M Buy
8,284
+1,270
+18% +$1.06M 0.36% 61
2024
Q4
$5.42M Buy
7,014
+104
+2% +$86.1K 0.33% 60
2024
Q3
$6.12M Buy
6,910
+46
+0.7% +$41.4K 0.43% 61
2024
Q2
$6.22M Buy
6,864
+1,346
+24% +$1.08M 0.51% 59
2024
Q1
$4.29M Buy
5,518
+109
+2% +$77.6K 0.42% 66
2023
Q4
$3.15M Buy
5,409
+125
+2% +$73K 0.37% 67
2023
Q3
$2.84M Buy
5,284
+1,665
+46% +$858K 0.42% 62
2023
Q2
$1.7M Buy
3,619
+122
+3% +$51.2K 0.26% 77
2023
Q1
$1.2M Buy
3,497
+331
+10% +$112K 0.2% 87
2022
Q4
$1.16M Sell
3,166
-338
-10% -$120K 0.21% 87
2022
Q3
$1.13M Sell
3,504
-676
-16% -$214K 0.23% 85
2022
Q2
$1.35M Sell
4,180
-23
-0.5% -$6.9K 0.26% 82
2022
Q1
$1.2M Buy
4,203
+142
+3% +$36.5K 0.2% 86
2021
Q4
$1.12M Sell
4,061
-536
-12% -$136K 0.18% 91
2021
Q3
$1.06M Buy
4,597
+2,313
+101% +$571K 0.18% 98
2021
Q2
$524K Buy
+2,284
New +$459K 0.14% 91

Other funds holding LLY

Stratos Investment Management's LLY Position: Q1 2026 in Review

Stratos Investment Management increased its Eli Lilly (LLY) stake by 19% in Q1 2026, buying an estimated $2.71M and bringing the position to 16,610 shares worth $15.3M. The position accounts for 0.61% of the portfolio, ranked #42.

Stratos Investment Management first reported a position in LLY in Q2 2021 and has held it in 20 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Stratos Investment Management held 16,610 shares of Eli Lilly worth $15.3M as of Q1 2026.
  • Stratos Investment Management bought 2,676 Eli Lilly shares in Q1 2026, an estimated $2.71M.
  • Eli Lilly made up 0.61% of Stratos Investment Management's portfolio in Q1 2026, its #42 holding.
  • Stratos Investment Management first reported a position in Eli Lilly in Q2 2021 and has held it in 20 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Stratos Investment Management's 13F filing for Q1 2026, filed 28 Apr 2026.